QA Inspector II - 2nd shift
![]() | |
![]() United States, New York, Central Islip | |
![]() 550 South Research Place (Show on map) | |
![]() | |
NOTICE: The posting for local applicants only - is not for those applying for a global assignment and/or for employees working outside of Cipla's U.S. Subsidiaries or Affiliates. Job Title: QA Inspector a" Packaging (2nd Shift) Location: Central Islip, NY (Onsite) Hourly rate: $18.72 - $26.00 Department: Quality Assurance Industry: Pharmaceutical Manufacturing / Packaging Reports To: QA Supervisor Position Overview: We are seeking a detail-oriented and motivated Quality Assurance (QA) Inspector to join our 2nd shift packaging operations. This role plays a critical part in ensuring product quality, adherence to cGMP standards, and compliance with internal and regulatory requirements. The QA Inspector will work cross-functionally to conduct quality inspections, support documentation accuracy, and drive continuous improvement efforts on the production floor. Key Responsibilities:
Required Skills & Competencies:
Physical Requirements:
Qualifications:
GLOBAL COMPANY Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded and generic medicines. We are trusted by healthcare professionals and patients across geographies. Over the last eight decades, we have strengthened our leadership in Indiaas pharmaceutical industry and fortified our promise of strengthening our global focus by consolidating and deepening our presence in the key markets of India, South Africa, the U.S., and other economies of the emerging world. Cipla employs handpicked professionals not just for their knowledge and experience but for their zeal to make a difference to the world of healthcare. The company believes that our biggest assets are the employees who lead us to prosperity and growth in the future. Driven by the vision, none shall be denied, Ciplaas focus has always been on making affordable, world-class medicines with a reputation for uncompromising quality standards across the world. CIPLA NEW YORK (INVAGEN PHARMACEUTICALS, INC.) About InvaGen Pharmaceuticals, a Cipla subsidiary InvaGen Pharmaceuticals, Inc. is engaged in the development, manufacture, marketing, and distribution of generic prescription medicines with focus on a range of therapeutic areas, including cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic, and anti-depressants. The company was founded in 2003 and is based in Central Islip and Hauppauge, New York. As of February 18, 2016, InvaGen Pharmaceuticals, Inc. operates as a subsidiary of Cipla (EU) Limited. |